探讨子宫内膜癌的临床分期及不同治疗方法对预后的影响。

选择1991年1月至1999年12月本院收治的子宫内膜癌病例125例(经术后病理证实)。根据临床分期及不同治疗方法将125例分为手术组、单纯放疗组、术前放疗组和术后放疗组4组，对其治疗后的疗效、复发、转移及并发症进行分析。

全组总的5年生存率为77. 6%。手术组、单纯放疗组、术前放疗组和术后放疗组的5年生存率分别为68. 2%,65. 5%,85. 3%,85. 0%。术前放疗组和术后放疗组的5年生存率明显高于手术组和单纯放疗组(P<0.05)。放疗后并发症中放射性直肠炎、膀胱炎的发生率，单纯放疗组分别为3.4%，0;术前放疗组分别为2.9%，0;术后放疗组分别为5.0%，2.5%。

采用手术加放射治疗的综合治疗方式，可提高子宫内膜癌患者的生存率，降低复发转移率，是目前治疗子宫内膜癌较为理想的方法。

To investigate the influence of different clinical stages and therapeutics on the prognosis of endometrial carcinoma.

From Jan. 1991 to Dec. 1999, 125 patients with endometrial carcinoma received treatment in our hospital. Their diagnosis had been confirmed by pathology. According to different clinical stages and therapeutics, we divided them into 4 groups: patients received operation only, radiotherapy only, radiotherapy before operation and radiotherapy after operation. Then we analysed their curative effect, relapse rate, metastasis rate and complication rate.

The overall survival rates at 5-year were 77. 6%. The survival rates at 5-year in each of the 4groups are: 68. 2% , 65. 5%, 85. 300%, 85. 0%. The survival rates of the third and fourth groups are significantly higher than the first and second groups (P<0. 05). Concerning rectitis and cystitis after radiotherapy, the complication rates in the second group are 3. 4% and 0, in the third group are 2. 9% and 0, in the fourth group are 5% and 2. 5%.

Operation combined with radiotherapy can improve the survival rate and reduce the relapse rate of endometrial carcinoma, which is an ideal therapeutic at the present time.